The role of accessibility policies and other determinants of health care provision in the initial prognosis of malignant melanoma: A cross-sectional study - 14/08/14
, Teresa Ojeda-Vila, MD a, Juan J. Ríos-Martín, PhD a, Ricardo Ruiz-Villaverde, PhD b, Magdalena de-Troya, PhD c, Andres Sanz-Trelles, PhD d, Rafael Fúnez Liébana, PhD c, José M. Martínez-de-Victoria, PhD b, Jose Aneiros-Fernández, PhD e, Ramón Naranjo-Sintes, PhD e, Joaquín Amérigo, PhD f, Mercedes Alcalde, PhD f, Teresa Zulueta, PhD g, Javier J. Domínguez-Cruz, MD g, Eduardo Solís-García, PhD h, Antonio Tejera-Vaquerizo, PhD h, Aurelio M. Martín-Castro, PhD i, Valentín García-Mellado, PhD i, Silvestre Martínez-García, PhD d, Araceli Martínez-García, PhD j, Enrique Herrera-Acosta, PhD j, Pilar Jurado Escámez, PhD k, Antonio M. Rodríguez-Fernández, PhD l, Juan Salvatierra-Cuenca, PhD m, José C. Moreno-Giménez, PhD m, Rosario Guerrero-Cauqui, PhD n, Jose C. Armario-Hita, PhD n, Adoración Nieto-Garcia, PhD o, Lara Ferrándiz, PhD aAbstract |
Background |
The prognostic benefit of health care service provision and delivery policies for patients with malignant melanoma (MM) is not yet clear.
Objective |
To analyze the role of health care provision determinants in the initial prognosis of MM.
Methods |
A multicenter cross-sectional study was conducted at 14 public hospitals and recruited 3550 patients with MM between 2000 and 2009. The study variables were analyzed using univariate and multivariate models to identify their role in the variations observed.
Results |
In a 10-year period, the number of patients with MM increased by 78.54%, with primary in situ MM (Tis) or MMs with a Breslow thickness <1 mm (T1) representing 51.72% of the total number of MMs in 2000, increasing to 62.23% by the end of the study period (P = .005). Among the variables that explained the variation in MM frequency the year of diagnosis after 2004 (univariate odds ratio [OR], 1.43 [P < .001]; multivariate OR, 1.36 [P = .005]) and diagnosis in centers with specific fast-track referral systems (univariate OR, 1.24 [P = .01]; multivariate OR, 1.59 [P = .025]) were shown to explain the increasing frequency of Tis-T1 MM.
Limitations |
The primary potential limitation of this study is its retrospective nature.
Conclusion |
Health care provision policies and interventions aimed at improving accessibility to specialized care appear to explain the increasing frequency of Tis-T1 MM.
Le texte complet de cet article est disponible en PDF.Key words : health care service provision, malignant melanoma, primary prevention, prognosis, secondary prevention, skin cancer, teledermatology
Abbreviations used : MM, OR, PCC, PHSA, TEDIMEL-A
Plan
| The Trends in Melanoma Diagnosis in Andalusia (TEDIMEL-A) Project Study Group is funded by a competitive public grant of the Health Institute Carlos III of the Spanish Health Ministry (IP 10-1929 2010-2013). |
|
| Conflicts of interest: None declared. |
|
| Reprints not available from the authors. |
Vol 71 - N° 3
P. 507-515 - septembre 2014 Retour au numéro
Article précédent
- Acquired idiopathic anhidrosis: A diagnosis often missed
- Liang Kiat Tay, Wei-Sheng Chong
- Clinicopathologic features and survival in Spitzoid malignant melanoma and conventional malignant melanoma
- Kristina Semkova, Jason P. Lott, Rossitza Lazova
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?